about
Monitoring cerebral oxygenation during balloon occlusion with multichannel NIRS.Bee Venom for the Treatment of Parkinson Disease - A Randomized Controlled Clinical TrialCorrection: Bee Venom for the Treatment of Parkinson Disease - A Randomized Controlled Clinical Trial.Outcome after thrombolysis for acute isolated posterior cerebral artery occlusion.Endovascular therapy of 623 patients with anterior circulation stroke.Plasma levels of mannan-binding lectin (MBL)-associated serine proteases (MASPs) and MBL-associated protein in cardio- and cerebrovascular diseases.Quality of life in survivors after cervical artery dissection.Clinical reasoning: rhabdomyolysis after combined treatment with simvastatin and fluconazole.Dopaminergic denervation severity depends on COMT Val158Met polymorphism in Parkinson's disease.Impact of admission glucose and diabetes on recanalization and outcome after intra-arterial thrombolysis for ischaemic stroke.Intracranial hemorrhage, outcome, and mortality after intra-arterial therapy for acute ischemic stroke in patients under oral anticoagulants.Trunk sway in mildly disabled multiple sclerosis patients with and without balance impairment.Diskogenic microspurs as a major cause of intractable spontaneous intracranial hypotension.Age-dependent differences in demographics, risk factors, co-morbidity, etiology, management, and clinical outcome of acute ischemic stroke.Keeping an Eye on This Headache.Stent placement in acute cerebral artery occlusion: use of a self-expandable intracranial stent for acute stroke treatment.Impact of Thrombolysis on Stroke Outcome at 12 Months in a Population[Pancytopenia and hemolysis--diagnosis, differential diagnosis and therapy of pernicious anemia]Coagulation factor XIII activation peptide and subunit levels in patients with acute ischaemic stroke: a pilot studyCervical polyradiculopathy caused by vertebral artery dissection
P50
Q30443283-83EB05B5-BBF4-42E8-BF3A-A49DB8937F64Q36073720-A04A75F0-CE7A-40D9-8213-EF5FF1925B8FQ42396948-891E3115-6CB1-42C2-975C-4E2D1EF92BA6Q43712173-4567BAE4-54D7-485E-9EC2-23B495D91E24Q43909924-22DF9CFA-CCB5-43ED-8BE9-AEC572DA6F5EQ44400729-F196AF23-359B-4A19-B857-2E4F2F878DC0Q44766063-E4563661-3C51-47C2-B3A3-DB21439EE8A2Q46329165-FD98B457-11A0-4962-A23F-9C63C395DF12Q48289986-87F67F6B-6B5A-4277-978B-509F7DA26F7FQ48379020-05B58252-ACF6-49D9-945D-10B54FA6BC9CQ48857689-C6EBA885-230F-4569-A2AB-9CB0253063A1Q49030141-F101FCC4-51C4-406C-B91D-53C93EEEBF57Q50590860-B68319CA-9173-410E-B381-A019212097D1Q51690447-05A586E9-8B88-418D-AF17-12149BBE1CC1Q52853859-35BCFC89-ABC6-40BD-AAFB-D0196A339050Q53371211-0F7BD2AE-1ABA-4DC0-B703-B6E5A30116F3Q58087924-3A4CC1B9-300B-4FCC-9DC5-19068075182AQ80510796-34C1D147-2A80-40A4-9F53-C5BC433B1D13Q84481515-5E4B2B66-9D61-4133-AE9A-676E8014D76CQ86667849-B872402D-67C5-44E6-87B8-42AE0D56C32C
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Niklaus Meier
@en
Niklaus Meier
@nl
type
label
Niklaus Meier
@en
Niklaus Meier
@nl
altLabel
Meier N
@en
prefLabel
Niklaus Meier
@en
Niklaus Meier
@nl
P31
P496
0000-0002-2900-0456